Defense Secretary Austin is 'actively involved and engaged' while hospitalized

Defense Secretary Austin is 'actively involved and engaged' while hospitalized


US Secretary of Defense Lloyd J. Austin testifies before a House Armed Services Committee hearing on the conclusion of military operations in Afghanistan at the Rayburn House Office building on Capitol Hill on September 29, 2021 in Washington, DC. 

Olivier Douliery | Afp | Getty Images

Defense Secretary Lloyd Austin is still hospitalized following doctors’ advice, but he’s “actively involved and engaged,” according to national security spokesperson John Kirby.

Appearing on CBS’s “Face the Nation” on Sunday, Kirby said that Austin took part in discussions planning strikes on Iran-allied Houthi militants in Yemen several days ago.

“It’s also important for people to remember that the cabinet officials don’t have to sit and talk every single day to make every decision,” Kirby said. “A lot of the work that gets done in national security is done at the staff level.”

Austin has been treated at Walter Reed National Military Medical Center since Jan. 1, following complications from a surgery nearly two weeks earlier to treat prostate cancer. Kirby said Sunday that physical therapy is part of the reason doctors have kept Austin in the hospital.

The Pentagon’s failure to disclose Austin’s hospital admittance to the White House or the public has stirred up controversy, although President Joe Biden is standing by Austin.

For two days, Pentagon officials also failed to tell Austin’s second-in-command that he transferred his authority over to her while he was in the intensive care unit.

“The Pentagon’s investigating this, and we’ll see what comes out of that, but that is not the way that the process is supposed to work,” Kirby said.



Source

Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale
Health

Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale

Jim Cramer says don’t sweat Novo Nordisk’s head start over Club holding Eli Lilly in the obesity pill market. Eli Lilly stock slipped about half a percent this morning, while Novo Nordisk shares surged more than 8% after becoming the first to secure FDA approval for a GLP-1 weight-loss pill. “[Novo] got approval ahead of […]

Read More
FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk
Health

FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, Nov. 24, 2025. Tom Little | Reuters The U.S. Food and Drug Administration on Monday approved the first-ever GLP-1 pill for obesity from Wegovy maker Novo Nordisk, a landmark decision that health experts […]

Read More
UnitedHealth Group commits to improvements after independent audit, patient backlash
Health

UnitedHealth Group commits to improvements after independent audit, patient backlash

UnitedHealthcare sign is displayed at its office building in Minnetonka, Minnesota, U.S., Dec. 11, 2025. Tim Evans | Reuters UnitedHealth Group on Friday released the first results from a sprawling independent audit of its business practices and committed to a wide range of steps to track and implement improvements in three specific areas. The health-care […]

Read More